EUVIMEDEUVIMED entdecken
Crossref

Tolerability of perampanel: A retrospective study at the department of psychiatry

Taiki Matsuyama, Toru Horinouchi, Yuichi Nakamura, Shuhei Ishikawa, Naoki Hashimoto, Ichiro Kusumi

Epilepsy & Behavior · 2024

DOI: 10.1016/j.yebeh.2024.109797 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von Taiki Matsuyama und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Wakkanai City Hospital, Wakkanai, Japan. Hauptthemen laut MEDLINE: Pyridones, Nitriles, Anticonvulsants, Mental Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: We aimed to identify factors that contribute to the discontinuation of perampanel. METHODS: We retrospectively analyzed patients with epilepsy at the Department of Psychiatry, Hokkaido University Hospital. We evaluated the factors contributing to perampanel discontinuation as primary outcomes using Cox proportional hazards regression. Then, we explored the components contributing to the primary outcomes using logistic regression analysis. RESULTS: A total of 118 patients were included, 44.9% of whom discontinued participation, 22.0% had intellectual disability, and 23.7% had a psychiatric disorder other than intellectual disability. Adverse effects occurred in 65% of the patients, 23.7% had psychiatric adverse effects (PAE), and 49.2% had common adverse effects (CAE). The effect of PER to suppress seizures was confirmed in 65.3% of them. Discontinuation was influenced by non-response (Hazard Ratio (HR) 6.70, 95% Confidence Interval (CI) 3.42-13.1), the occurrence of PAE (HR 3.68, 95% CI 1.89-7.16), CAE (HR 1.90, 95% CI 1.06-3.41), and comorbid psychiatric disorders (HR 2.35, 95% CI 1.21-4.59). Moreover, comorbid intellectual disability correlated with a low risk of PAE (OR 0.19, 95% CI 0.04-0.89). CONCLUSION: The discontinuation of perampanel is influenced by poor efficacy and the occurrence of common/psychiatric adverse effects. The discontinuation of perampanel is influenced by poor efficacy and the occurrence of common/psychiatric adverse effects. Consideration of factors contributing to perampanel discontinuation may assist in determining the indication for perampanel treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridonesNitrilesAnticonvulsantsMental DisordersHumansFemaleMaleRetrospective StudiesMiddle AgedAdultEpilepsyAgedYoung AdultIntellectual DisabilityAdolescent

Stichwörter der Autor:innen

Anti-seizure medicationIntellectual disabilityPerampanelPsychiatric adverse effectsPsychiatric comorbidity

Substanzen

perampanelPyridonesNitrilesAnticonvulsants

Autor:innen und Institutionen

  • Department of Psychiatry, Wakkanai City Hospital, Wakkanai, Japan.
  • Department of Psychiatry, Hokkaido University Hospital, Sapporo, Japan. Electronic address: toruhorinouchi1234@gmail.com.
  • Department of Psychiatry, Hokkaido University Hospital, Sapporo, Japan.

Zitieren

APA

Matsuyama, T., Horinouchi, T., Nakamura, Y., Ishikawa, S., Hashimoto, N., & Kusumi, I. (2024). Tolerability of perampanel: A retrospective study at the department of psychiatry. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.109797

Vancouver

Matsuyama T, Horinouchi T, Nakamura Y, Ishikawa S, Hashimoto N, Kusumi I. Tolerability of perampanel: A retrospective study at the department of psychiatry. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2024.109797

BibTeX
@article{Matsuyama2024,
  author = {Matsuyama, Taiki and Horinouchi, Toru and Nakamura, Yuichi and Ishikawa, Shuhei and Hashimoto, Naoki and Kusumi, Ichiro},
  title = {Tolerability of perampanel: A retrospective study at the department of psychiatry},
  journal = {Epilepsy & Behavior},
  year = {2024},
  doi = {10.1016/j.yebeh.2024.109797}
}
Kostenlos starten →